JPRN-UMIN000008466
Completed
Phase 2
Clinical study on the efficacy of recombinant thrombomodulin for DIC complicated with acute leukemia - Efficacy of recombinant thrombomodulin for DIC complicated with acute leukemia
TOHOKU HEMATOLOGY FORUM0 sites50 target enrollmentJuly 18, 2012
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Disseminated intravascular coagulation (DIC) complicated with acute leukemia
- Sponsor
- TOHOKU HEMATOLOGY FORUM
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who have DIC caused by infection. 2\)Patients expected to live less than one month. 3\)Patients who will receive palliative care only. 4\)Patients who have a history of severe drug allergy 5\)Patients currently treated with anticoagulation drugs, and cannot stop them. 6\)Patients whose protein C activity is less than 10%. 7\) Women during pregnancy, possible pregnancy or breast\-feeding 8\)Severe mental disease 9\)Inadequate for clinical trial entry by the attending physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Clinical study on anal administration of drugs (basti) along with oral medicine in the management of obesityHealth Condition 1: null- obesityCTRI/2017/08/009215ational Insytitute of Ayurveda
Not yet recruiting
Phase 2
To compare the efficacy of Trimurti lepa against Jirakadi lepa in scorpion sting with Dasanga gulika as common internal medicineCTRI/2023/09/058105VPSV Ayurveda college Kottakkal
Recruiting
Not Applicable
Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical careJPRN-UMIN000006580Critical Care Medicine, Nara Hospital, Kinki University School of Medicine20
Not yet recruiting
Not Applicable
Efficacy and safety of recombinant human thrombomodulin for the patients with coagulopathy before cardiovascular surgeryaortic aneurysmJPRN-UMIN000010632Yutaka Okita10
Completed
Not Applicable
Therapeutic effects of recombinant human soluble thrombomodulin in patients with DIC caused by severe burns:a historical control clinical trial.DIC caused by severe burnsJPRN-UMIN000007965Yokohama City University Medical Center10